Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone: Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (SWIFT)

NCT04762537 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT04762537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04762537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone: Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (SWIFT)
Lead sponsor
New York State Psychiatric Institute
Phase
Not applicable
Overall status
Completed
Start date
March 16, 2021
Completion date
December 21, 2022
Enrollment
415 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-use disorder